BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 12, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 2, 2003
View Archived Issues
AlphaVax receives biodefense grants
Read More
Phase II study evaluates Remune in HIV patients in Italy
Read More
SBIR grant will help fund development of CEL-1000 for vaccinia and smallpox infections
Read More
Nabi commences confirmatory phase III trial of StaphVAX ahead of schedule
Read More
NIAID award funds work at Progenics on prophylactic HIV vaccine
Read More
XMP-629 enters phase I trial for topical treatment of acne
Read More
SARS vaccine development at Baxter boosted by NIAID award
Read More
CO-501 enters clinical testing
Read More
Positive phase III results for Actiza
Read More
New antifungal agents presented by OGS researchers
Read More
VR1 antagonists for urinary incontinence and pain claimed by Abbott
Read More
GSK patents cover novel NK1 antagonists, their preparation and use
Read More
New CXCR3 antagonists described in Celltech R&D patent
Read More
KuDOS patent describes ATM inhibitors with potential in cancer and HIV therapy
Read More
Lilly scientists design new PPARalpha/PPARgamma modulators
Read More
Data monitoring committee recommends continuation of phase III Cubicin study
Read More
deCODE discovers gene in obesity alliance with Merck
Read More
Combination therapy with SERMs for osteopenia
Read More
Clinical evidence of teriparatide efficacy grows
Read More
Final Panzem formulations selected
Read More
AMG-162 demonstrates beneficial pharmacokinetics, activity in osteoporosis
Read More
Cinacalcet effective in preclinical and clinical studies
Read More
Inex begins submission of rolling NDA for Onco TCS
Read More
Expansion of phase III Virulizin trial
Read More
Dexanabinol receives fast track designation for traumatic brain injury
Read More
Tarceva fails to meet primary endpoint in two phase III NSCLC trials
Read More
Excellent activity demonstrated by new fluoroquinolone against multidrug-resistant staphylococci
Read More
Low-molecular-weight antiangiogenic agent effective in mouse model of brain cancer
Read More